Search Result "Crizotinib"
Crizotinib Versus Chemotherapy on ALK-positive NSCLC: A Systematic Review of Efficacy and Safety
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 41-49
Author(s): Mingxia Wang,Guanqi Wang,Haiyan Ma,Baoen Shan
Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted Therapies
Journal: Current Clinical Pharmacology
Volume: 11 Issue: 2 Year: 2016 Page: 77-87
Author(s): Francesca Casaluce,Assunta Sgambato,Paola Claudia Sacco,Giovanni Palazzolo,Paolo Maione,Antonio Rossi,Fortunato Ciardiello,Cesare Gridelli
CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 8 Year: 2019 Page: 655-665
Author(s): Caixia Liang,Ningning Zhang,Qiaoyun Tan,Shuxia Liu,Rongrong Luo,Yanrong Wang,Yuankai Shi,Xiaohong Han
Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 940-950
Author(s): Amir Avan,Karl Quint,Francesco Nicolini,Niccola Funel,Adam E. Frampton,Mina Maftouh,Serena Pelliccioni,Gerrit J. Schuurhuis,Godefridus J. Peters,Elisa Giovannetti
Current Strategies to Overcome Resistance to ALK-Inhibitor Agents
Journal: Current Drug Metabolism
Volume: 16 Issue: 7 Year: 2015 Page: 585-596
Author(s): Francesca Simionato,Melissa Frizziero,Carmine Carbone,Giampaolo Tortora,Davide Melisi
Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 6 Year: 2017 Page: 590-613
Author(s): Jingru Liu,Shutao Ma
Novel Compounds and Drugs and Related Patents in Lung Cancer Chemotherapy
Ebook: Topics in Anti-Cancer Research
Volume: 4 Year: 2015
Author(s): Attapon Cheepsattayakorn,Ruangrong Cheepsattayakorn
Doi: 10.2174/9781681080765115040014
Prospecting for New Inhibitors of Anaplastic Lymphoma Kinase, A Clinically Relevant Oncogenic Drug Target
Journal: Current Bioactive Compounds
Volume: 13 Issue: 3 Year: 2017 Page: 236-243
Author(s): Daniel F. Kawano,Carlton A. Taft,Carlos H.T.P. da Silva
Targeting c-MET/HGF Signaling Pathway in Upper Gastrointestinal Cancers: Rationale and Progress
Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1302-1311
Author(s): Sharareh Gholamin,Hamid Fiuji,Mina Maftouh,Reza Mirhafez,Fatemeh Homaei Shandiz,Amir Avan
Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer
Journal: Current Drug Targets
Volume: 17 Issue: 6 Year: 2016 Page: 739-745
Author(s): David M. Straughan, Sa d C. Azoury, Vivek Shukla